Publications | PubMed=758928; DOI=10.1038/bjc.1979.3; PMCID=PMC2009802 Kinjo M., Oka K., Naito S., Kohga S., Tanaka K., Oboshi S., Hayata Y., Yasumoto K. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br. J. Cancer 39:15-23(1979) PubMed=3731100 Hanai N., Shitara K., Yoshida H. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res. 46:4438-4443(1986) PubMed=8385084; DOI=10.1111/j.1349-7006.1993.tb02851.x; PMCID=PMC5919128 Suzuki S., Takahashi T., Nakamura S., Koike K., Ariyoshi Y., Takahashi T., Ueda R. Alterations of integrin expression in human lung cancer. Jpn. J. Cancer Res. 84:168-174(1993) PubMed=8263009; DOI=10.1007/BF01202192 Kashii T., Mizushima Y., Monno S., Nakagawa K., Kobayashi M. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method. J. Cancer Res. Clin. Oncol. 120:143-148(1994) PubMed=10536175; DOI=10.3892/ijo.15.5.927 Fujita T., Kiyama M., Tomizawa Y., Kohno T., Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int. J. Oncol. 15:927-934(1999) PubMed=11005564; DOI=10.1038/sj.neo.7900094; PMCID=PMC1550293 Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J. Mutation and expression of the DCC gene in human lung cancer. Neoplasia 2:300-305(2000) PubMed=11583962; DOI=10.1016/S0002-9440(10)62521-7; PMCID=PMC1850523 Haruki N., Harano T., Masuda A., Kiyono T., Takahashi T., Tatematsu Y., Shimizu S., Mitsudomi T., Konishi H., Osada H., Fujii Y., Takahashi T. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am. J. Pathol. 159:1345-1352(2001) PubMed=12794755; DOI=10.1002/ijc.11184 Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int. J. Cancer 106:45-51(2003) PubMed=14581340 Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin. Cancer Res. 9:4705-4713(2003) PubMed=15185009; DOI=10.1007/s00262-004-0533-9; PMCID=PMC11034254 Yamaji H., Iizasa T., Koh E., Suzuki M., Otsuji M., Chang H., Motohashi S., Yokoi S., Hiroshima K., Tagawa M., Nakayama T., Fujisawa T. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol. Immunother. 53:786-792(2004) PubMed=15746151; DOI=10.1093/hmg/ddi092 Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., Hirohashi S., Inazawa J., Imoto I. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum. Mol. Genet. 14:997-1007(2005) PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702 Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K. Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci. 98:1048-1054(2007) PubMed=19472407; DOI=10.1002/humu.21028; PMCID=PMC2900846 Blanco R., Iwakawa R., Tang M.-Y., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M. A gene-alteration profile of human lung cancer cell lines. Hum. Mutat. 30:1199-1206(2009) PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x; PMCID=PMC11158680 Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J. Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Sci. 101:1891-1896(2010) PubMed=23381221; DOI=10.3892/or.2013.2266; PMCID=PMC3621652 Suzuki M., Shiraishi K., Eguchi A., Ikeda K., Mori T., Yoshimoto K., Ohba Y., Yamada T., Ito T., Baba Y., Baba H. Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer. Oncol. Rep. 29:1308-1314(2013) PubMed=25120651; DOI=10.3892/ol.2014.2234; PMCID=PMC4114630 Suzuki M., Ikeda K., Shiraishi K., Eguchi A., Mori T., Yoshimoto K., Shibata H., Ito T., Baba Y., Baba H. Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer. Oncol. Lett. 8:1025-1030(2014) |